Ping An Good Doctor Partners With Pfizer China to Build Integrated Medical-Pharmaceutical-Insurance Ecosystem on July 7

According to Zhitong Caijing, on July 7, Ping An Good Doctor and Pfizer China established a strategic partnership to build dual-loop ecosystem linking medical services, innovative drugs, insurance coverage, and patient management. The collaboration will develop single-disease insurance products, integrate Pfizer's innovative drugs onto Ping An's platform, and establish full-cycle disease management covering screening, patient education, standardized treatment, and long-term follow-up.

Both parties will expand cooperation in oncology, rare diseases, vaccines, and metabolic health management, combining digital health capabilities with risk assessment and standardized treatment protocols.